The Centers for Medicare & Medicaid Services (CMS) recently released the Final Rate Announcement for Calendar Year (CY) 2025. The announcement finalized a payment increase of 3.7% over CY 2024, which (as we previously reported) represents no significant change from the Advance Notice published on January 31, 2024. According to AHIP, many Medicare Advantage (MA) plans believe these policies “will put even more pressure on benefits and premiums” for their plans.
This update, created in partnership with our consulting actuaries, summarizes the implications to health plans and, more importantly, outlines the key actions health plans need to consider in light of these changes.
The Final Rate Announcement includes a small decrease in the effective growth rate from the Advance Notice. However, changes are not uniform in all states and counties. Two significant updates (growth rate calculation methodology and Part C risk model) will continue to be phased in over three years.
Individual MA growth rates decreased 0.11% for the Final Notice vs. the Advance Notice. This adjustment is due to the inclusion of more recent payment data, up to the fourth quarter of 2023. It is important to note that the impact to individual counties’ benchmarks varies.
CMS modified the phase-in of a technical change to remove MA-related indirect medical education and direct graduate medical education costs paid to hospitals from the expenditures supporting the fee-for-service (FFS) United States per capita costs (USPCC) estimates. While initially proposed for a 67% adjustment in 2025, CMS has lowered that factor to 52%. The impact of the increase in phase-in from 33% to 52% is about a 0.5% reduction in 2025 trend.
Star Ratings updates include the list of eligible disasters for adjustment, non-substantive measure specification updates, and the list of measures included in the Part C and D Improvement measures and Categorical Adjustment Index for the 2025 Star Ratings.
Part C risk scores will continue to be developed using a recalibrated hierarchical condition category (HCC) model, with 2025 being the second year of a three-year phase-in. As previously proposed, risk scores will be developed, weighting two-thirds on the new model and one-third on the current model for 2025. The new model includes a clinical update to the HCCs based on ICD-10-CM (vs. ICD-9-CM) diagnosis codes, and an update to the data years (2018 diagnoses and 2019 expenditures) based on the risk adjustment allowable CPT/HCPCS codes. The Part D HCC risk model is changing due to Inflation Reduction Act (IRA) changes.
Updates include the elimination of the coverage gap phase to implement a three-phase benefit (deductible, initial coverage, and catastrophic) and the addition of a cap on out-of-pocket costs at $2,000 for CY 2025.
Bid-To-Benchmark (B2B) ratios have steadily declined over the last five years. A 100% quartile county’s B2B ratio has decreased for Employer Group Waiver Plan (EGWP) rate development for 2021 through 2025 as follows: 85.1%, 82.6%, 79.8%, 77.2%, 76.7%. The impact of this rising competitiveness on the part of individual plans puts downward pressure on EGWP rates.
Amid the outlook of continued financial pressure, MA plans will need to navigate the forthcoming changes and optimize their competitive positioning. We outline three critical strategies plans should prioritize in the near-term.
The healthcare landscape is constantly evolving, and keeping pace with regulatory changes and market shifts can be challenging for MA plans. We partner with plans nationwide to navigate these changes and achieve optimal performance.